NEW YORK] A biotech stock focused on herbal medicine has surged by more than 64,000 per cent so far this year and yet, the ...

For the quarter, the Voya MidCap Opportunities Fund underperformed the Index on a NAV basis due largely to selection effects.

The de-escalation of therapy helps avoid unnecessary toxicity from treatment in patients with brain cancer, explained Drs.

In conversation with Fierce Biotech’s Chris Hayden, Austin Read, head of PPD™ CorEvitas™ Precision Medicine, Thermo Fisher ...

China’s AI upstart DeepSeek shook the tech industry and stock markets earlier this year by proving to be amazingly capable despite accessing relatively limited resources, such as chips. It has gone on ...

DeepSeek's advancements were inevitable, but the company brought them forward a few years earlier than would have been possible otherwise.

University of Cincinnati discusses the potential of agentic AI, autonomous systems capable of acting with minimal human ...

By removing the pull of gravity, space has accelerated breakthroughs once thought impossible, reshaping medicine, ...

The AI landscape is transforming at an unprecedented pace, unveiling new advances daily. However, enterprise-level AI innovation remains challenged by its complexity, as organizations must navigate ...

For nearly three years now, Nvidia (NVDA) has seemingly had AI hardware locked up tighter than Fort Knox. The company’s GPUs ...

Yep, Google and Microsoft are ahead now, but taking the time to deliver a thoughtful, truly useful AI approach is very Apple, and it's ultimately the right move.

A new cancer treatment discovered by the University of California San Diego Sanford Stem Cell Institute (SSCI) and developed ...